DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Trazodone Hydrochloride is a drug marketed by Accord Hlthcare, Alvogen, Am Therap, Apotex, Apotex Inc, Aurolife Pharma Llc, Fosun Pharma, Mylan, Mylan Pharms Inc, Oxford Pharms, Pliva, Quantum Pharmics, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent, Usl Pharma, Watson Labs, and Zydus Pharms. and is included in twenty-nine NDAs.
The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
A generic version of TRAZODONE HYDROCHLORIDE was approved as trazodone hydrochloride by APOTEX on March 25th, 1987.
Summary for TRAZODONE HYDROCHLORIDE
|Suppliers / Packagers:||35|
|Bulk Api Vendors:||96|
|Formulation / Manufacturing:||see details|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for TRAZODONE HYDROCHLORIDE|
|DailyMed Link:||TRAZODONE HYDROCHLORIDE at DailyMed|
Recent Clinical Trials for TRAZODONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|VA Office of Research and Development||Phase 3|
|Erich Seifritz||Phase 2|
|Chang Gung Memorial Hospital||Phase 4|
Pharmacology for TRAZODONE HYDROCHLORIDE
|Drug Class||Serotonin Reuptake Inhibitor |